Gary Schwitzer, whose Health News Review should be your first stop for evaluating health and medicine journalism, has a quick line up of the good and the ugly in the coverage of the recent leukemia gene therapy study. Notice I didn't say "cure for cancer." Notably, neither did the good reporting that Schwitzer highlighted on his blog. More to come...